Status:
UNKNOWN
Bispectral Index(BIS) on Depth of Sedation With Dexmedetomidine, Propofol and Midazolam During Spinal Anesthesia
Lead Sponsor:
Hallym University Medical Center
Conditions:
Sedation
Anesthesia, Spinal
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
This study is to investigate on the objective relevance between bispectral index (BIS) and Observer's assessment of alertness/sedation (OAA/S) scale in patients sedated with Midazolam, propofol and de...
Detailed Description
Sedation is an important element of regional anesthesia during surgery, which allows to finish surgery smoothly by reducing patients' anxiety and fear who undergo regional and local anesthesia. If ad...
Eligibility Criteria
Inclusion
- Patients who scheduled for knee arthroscopic surgery under spinal anesthesia
Exclusion
- Patients with a history of hepatic, renal, cardiovascular disease, and those who have allergy to study drugs (dexmedetomidine, propofol, midazolam).
- Hemodynamically unstable patients.
- Patients who is noncommunicative.
Key Trial Info
Start Date :
September 5 2016
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 31 2018
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT03399019
Start Date
September 5 2016
End Date
March 31 2018
Last Update
January 16 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hallym University Sacred Heart Hospital
Anyang-si, Gyeonggi-do, South Korea, KS009